News & Insights

GAO Report: CMS Needs to Broaden Opioid Efforts to Identify and Address Those at Risk for Serious Harm

The Centers for Medicare and Medicaid Services (CMS) have focused for years on identifying opioid-treated beneficiaries at risk for serious harm such as overdose or addiction. Their approach has concentrated on patients prescribed high daily doses of opioids who also have indicators of opioid misuse or abuse, such as ‘doctor shopping’ (multiple prescribers and pharmacies). […]

Eight Steps of Quality Control in Scientific Writing

A smooth and effective quality control process involves establishing guidelines at the beginning of the research and writing process, and then ensuring accuracy and consistency from start to finish. Here are eight steps towards good quality control in scientific writing. 1. Track your data We’ve all heard time and time again to make sure your […]

Venebio to Demo Opioid Overdose Risk-Screening Tool, Venebio Opioid Advisor, at Health 2.0

Demo to be part of breakout session, “Platforms for Provider Decision Support,” on Monday, October 2, at 11:30 a.m. in Grand Ballroom D Venebio Group, a leader in personalized risk prediction algorithms, will be demoing its risk-screening tool for prescription opioid overdose, Venebio Opioid Advisor™ (VOA™), at the 11th annual Health 2.0 conference in Santa […]

5 differences between a systematic review and other types of literature review

There are many types of reviews of the medical and public health evidence, each with its own benefits and challenges. In this blog post, we detail five key differences between a systematic review and other types of reviews, including narrative and comprehensive reviews. First, we must define some terms. “Literature review” is a general term […]

Second Health Plan to Implement Venebio’s Opioid Overdose Risk-Screening Tool

Recently published white paper estimates tool could result in 15% fewer prescription opioid overdoses RICHMOND, Va. (September 22, 2017) – Venebio Group, a leader in personalized risk prediction algorithms, today announced that Amida Care, a New York-based health plan provider, has implemented Venebio Opioid Advisor™ (VOA™), the company’s risk-screening tool for prescription opioid overdose. Amida […]

Substance Use Disorder Terminology Clarified

Diagnostic terminology in the field of substance use disorders (SUD) has become complicated, nuanced and open to interpretation by researchers and practitioners in different fields. Its tortured history is reflected in confusion among experts and non-experts alike. The glossary below may help clarify some common SUD-related definitions to provide some guidance as we continue conversations […]

Five questions to ask before you choose a target journal for publication

When you’ve spent, weeks, months – even years – working on a publication, you want to make sure you find the perfect journal to review and publish your findings. Targeting an inappropriate journal can result in extreme delays in time to publication or reaching an unsuitable or too small reading audience, among other things. Don’t […]

Predictive Analytics in the Public Health Arena

Millions of series of zeros and ones are behind everything we do as scientific research and healthcare professionals. We’re able to process this data through dozens of different lenses, but what gets us truly excited is the growing ability to use predictive analytics to improve population health. Venebio’s focus in predictive analytics has typically aligned […]

Venebio presents at ISPOR 2017

Recent legislative changes such as the Patient Protection and Affordable Care Act, HITECH, and the Medicare Access and CHIP Reauthorization Act are forcing the health care industry to find ways to improve quality and outcomes while lowering costs. Information technology and predictive analytics are being explored to identify viable, “cost-neutral” solutions to help achieve those […]

Recipe for the perfect meta-analysis

So, you’ve conducted a systematic review of the evidence on your topic, and you’re not sure whether you can—or should—combine the data quantitatively. It’s a common question, and there’s no “right” answer. However, the following considerations can help guide you toward the best decision. How many studies? One of the most frequently asked questions in […]